Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Non-squamous Non-small-cell Lung Cancer × famitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Non-squamous Non-small-cell Lung Cancer 1 Non Squamous Non Small Cell Lung 1 Gastrointestinal Stromal Tumors 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced NSCLC 1

Interventions

Carboplatin 2 famitinib 1 camrelizumab 1 Paclitaxel 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04619433 2025-09-23

A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Terminated

Non-squamous Non-small-cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡